Graftless TSFE Via Self-tapping Implants
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorSana'a University
About this trial
This prospective clinical trial aims to evaluate the efficiency, safety, and reliability of a minimally invasive graftless transcrestal sinus lifting approach with simultaneous dental implant placement in patients with edentulous posterior maxilla and limited residual bone height.
The study investigates bone formation beneath the Schneiderian membrane, implant stability, osseointegration, and long-term implant survival.
Eligibility criteria
Qualifiers
Adults aged 18-80 years.
Patients with edentulous posterior maxilla.
Residual bone height approximately 4-6 mm.
Indicated for transcrestal sinus membrane elevation.
Disqualifiers
Severe systemic diseases (ASA III or above).
Uncontrolled diabetes mellitus.
Active sinus pathology.
History of radiotherapy in the head and neck region.
Trial design
Treatments tested in this trial
- Graftless Transcrestal Sinus Membrane Elevation with Simultaneous Implant Placement
Treatment groups
20 Participants
are divided into 1 treatment groupLocations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Department of Oral and Maxillofacial Surgery, Sana'a UniversityRecruiting00000, Sanaa, Sanaa Governorate
Yemen
YemenSponsors and collaborators
Source ClinicalTrials.gov